Dissemination of multidrug-resistant, class.1 integron-carrying Acinetobacter baumannii isolates in Taiwan

Clinical Microbiology and Infection

Volumn 14, Issue 11, 2008, Pages 1010-1019

  Huang, L Y ^a   Chen, T L ^a,b   Lu, P L ^c   Tsai, C A ^d   Cho, W L ^b   Chang, F Y ^e   Fung, C P ^a,b   Siu, L K ^e,f  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^e National Defence Medical Centre   (Canada)

^f NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Acinetobacter baumannii; Epidemic clone; Integron associated; Multidrug resistant; Ribotype

Indexed keywords

AMIKACIN; AZTREONAM; BETA LACTAMASE; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; GENE PRODUCT; GENTAMICIN; IMIPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; PROTEIN AAC(6') II; PROTEIN AACA4; PROTEIN AACC1; PROTEIN AADA1; PROTEIN AADA2; PROTEIN AADA4; PROTEIN AADDA1; SULTAMICILLIN; TOBRAMYCIN; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM ISOLATE; GENE CASSETTE; GENE IDENTIFICATION; INTEGRON; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; MOLECULAR TYPING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RIBOTYPING; TAIWAN;

ACINETOBACTER BAUMANNII;

EID: 56849102998     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2008.02077.x     Document Type: Article

References (47)

1. Garnacho-Montero J, Ortiz-Leyba C, Fernandez-Hinojosa E et al. Acinetobacter baumannii ventilator-associated pneumonia: Epidemiological and clinical findings. Intensive Care Med 2005; 31: 649-655.
2. Cisneros JM, Rodriguez-Bano J. Nosocomial bacteremia due to Acinetobacter baumannii: Epidemiology, clinical features and treatment. Clin Microbiol Infect 2002; 8: 687-693.
3. Fournier PE, Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis 2006; 42: 692-699.
4. McGowan JE Jr. Resistance in nonfermenting gram-negative bacteria: multidrug resistance to the maximum. Am J Infect Control 2006; 34 (suppl): 29-37.
5. Bergogne-Berezin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: Microbiological, clinical, and epidemiological features. Clin Microbiol Rev 1996; 9: 148-165.
6. Mazel D. Integrons: Agents of bacterial evolution. Nat Rev Microbiol 2006; 4: 608-620.
7. Depardieu F, Podglajen I, Leclercq R et al. Modes and modulations of antibiotic resistance gene expression. Clin Microbiol Rev 2007; 20: 79-114.
8. Turton JF, Kaufmann ME, Glover J et al. Detection and typing of integrons in epidemic strains of Acinetobacter baumannii found in the United Kingdom. J Clin Microbiol 2005; 43: 3074-3082.
9. Koeleman JG, Stoof J, van der Bijl MW et al. Identification of epidemic strains of Acinetobacter baumannii by integrase gene PCR. J Clin Microbiol 2001; 39: 8-13.
10. Liu SY, Lin JY, Chu C et al. Integron-associated imipenem resistance in Acinetobacter baumannii isolated from a regional hospital in Taiwan. Int J Antimicrob Agents 2006; 27: 81-84.
11. Wu TL, Ma L, Chang JC et al. Variable resistance patterns of integron-associated multidrug-resistant Acinetobacter baumannii isolates in a surgical intensive care unit. Microb Drug Resist 2004; 10: 292-299.
12. Falagas ME, Koletsi PK, Bliziotis IA. The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. J Med Microbiol 2006; 55: 1619-1629.
13. Chen TL, Siu LK, Wu RC et al. Comparison of one-tube multiplex PCR, automated ribotyping and intergenic spacer (ITS) sequencing for rapid identification of Acinetobacter baumannii. Clin Microbiol Infect 2007; 13: 801-806.
14. Ploy MC, Denis F, Courvalin P et al. Molecular characterization of integrons in Acinetobacter baumannii: Description of a hybrid class.2 integron. Antimicrob Agents Chemother 2000; 44: 2684-2688.
15. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 15th informational supplement. M100-S15. Wayne, PA: CLSI, 2005.
16. Poirel L, Menuteau O, Agoli N et al. Outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital. J Clin Microbiol 2003; 41: 3542-3547.
17. Poirel L, Le TI, Naas T et al. Biochemical sequence analyses of GES-1, a novel class.A extended-spectrum beta-lactamase, and the class.1 integron In52 from Klebsiella pneumoniae. Antimicrob Agents Chemother 2000; 44: 622-632.
18. Brasme L, Nordmann P, Fidel F et al. Incidence of class.A extended-spectrum beta-lactamases in Champagne-Ardenne (France): A 1.year prospective study. J Antimicrob Chemother 2007; 60: 956-964.
19. Pasteran F, Rapoport M, Petroni A et al. Emergence of PER-2 and VEB-1a in Acinetobacter baumannii strains in the Americas. Antimicrob Agents Chemother 2006; 50: 3222-3224.
20. Heritier C, Poirel L, Lambert T et al. Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii. Antimicrob Agents Chemother 2005; 49: 3198-3202.
21. Seifert H, Dolzani L, Bressan R et al. Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J Clin Microbiol 2005; 43: 4328-4335.
22. Tenover FC, Arbeit RD, Goering RV et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233-2239.
23. Gu B, Tong M, Zhao W et al. Prevalence and characterization of class.I integrons among Pseudomonas aeruginosa and Acinetobacter baumannii isolates from patients in Nanjing, China. J Clin Microbiol 2007; 45: 241-243.
24. Gallego L, Towner KJ. Carriage of class.1 integrons and antibiotic resistance in clinical isolates of Acinetobacter baumannii from northern Spain. J Med Microbiol 2001; 50: 71-77.
25. Chiu CH, Su LH, Chu CH et al. Detection of multidrug-resistant Salmonella enterica serovar typhimurium phage types DT102, DT104, and U302 by multiplex PCR. J Clin Microbiol 2006; 44: 2354-2358.
26. Levings RS, Lightfoot D, Partridge SR et al. The genomic island SGI1, containing the multiple antibiotic resistance region of Salmonella enterica serovar Typhimurium DT104 or variants of it, is widely distributed in other S. enterica serovars. J Bacteriol 2005; 187: 4401-4409.
27. Shi L, Zheng M, Xiao Z et al. Unnoticed spread of class.1 integrons in gram-positive clinical strains isolated in Guangzhou, China. Microbiol Immunol 2006; 50: 463-467.
28. Fournier PE, Vallenet D, Barbe V et al. Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet 2006; 2: E7.
29. Roberts MC. Multidrug-resistant genes are associated with an 86-kb island in Acinetobacter baumannii. Trends Microbiol 2006; 14: 375-378.
30. Houang ET, Chu YW, Lo WS et al. Epidemiology of rifampin ADP-ribosyltransferase (arr-2) and metallo-beta-lactamase (bla IMP-4) gene cassettes in class.1 integrons in Acinetobacter strains isolated from blood cultures in 1997 to 2000. Antimicrob Agents Chemother 2003; 47: 1382-1390.
31. Yan JJ, Ko WC, Wu JJ. Identification of a plasmid encoding SHV-12, TEM-1, and a variant of IMP-2 metallo-beta-lactamase, IMP-8, from a clinical isolate of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001; 45: 2368-2371.
32. Valenzuela JK, Thomas L, Partridge SR et al. Horizontal gene transfer in a polyclonal outbreak of carbapenem-resistant Acinetobacter baumannii. J Clin Microbiol 2007; 45: 453-460.
33. Ruiz J, Navia MM, Casals C et al. Integron-mediated antibiotic multiresistance in Acinetobacter baumannii clinical isolates from Spain. Clin Microbiol Infect 2003; 9: 907-911.
34. Rather PN, Munayyer H, Mann PA et al. Genetic analysis of bacterial acetyltransferases: Identification of amino acids determining the specificities of the aminoglycoside 6′-N-acetyltransferase Ib and IIa proteins. J Bacteriol 1992; 174: 3196-3203.
35. Lee MD, Sanchez S, Zimmer M et al. Class.1 integron-associated tobramycin-gentamicin resistance in Campylobacter jejuni isolated from the broiler chicken house environment. Antimicrob Agents Chemother 2002; 46: 3660-3664.
36. Vila J, Marti S, Sanchez-Cespedes J. Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. J Antimicrob Chemother 2007; 59: 1210-1215.
37. Bonomo RA, Szabo D. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin Infect Dis 2006; 43 (suppl 2): 49-56.
38. Babic M, Hujer AM, Bonomo RA. What's new in antibiotic resistance? Focus on beta-lactamases. Drug Resist Update 2006; 9: 142-156.
39. Tsakris A, Ikonomidis A, Pournaras S et al. VIM-1 metallo-beta-lactamase in Acinetobacter baumannii. Emerg Infect Dis 2006; 12: 981-983.
40. Poirel L, Pitout JD, Nordmann P. Carbapenemases: Molecular diversity and clinical consequences. Future Microbiol 2007; 2: 501-512.
41. Martinez-Freijo P, Fluit AC, Schmitz FJ et al. Class.I integrons in Gram-negative isolates from different European hospitals and association with decreased susceptibility to multiple antibiotic compounds. J Antimicrob Chemother 1998; 42: 689-696.
42. Martinez-Freijo P, Fluit AC, Schmitz FJ et al. Many class.I integrons comprise distinct stable structures occurring in different species of Enterobacteriaceae isolated from widespread geographic regions in Europe. Antimicrob Agents Chemother 1999; 43: 686-689.
43. Leverstein-van Hall MA, Box AT, Blok HE et al. Evidence of extensive interspecies transfer of integron-mediated antimicrobial resistance genes among multidrug-resistant Enterobacteriaceae in a clinical setting. J Infect Dis 2002; 186: 49-56.
44. Michael CA, Gillings MR, Holmes AJ et al. Mobile gene cassettes: A fundamental resource for bacterial evolution. Am Nat 2004; 164: 1-12.
45. Corvec S, Caroff N, Espaze E et al. AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strains. J Antimicrob Chemother 2003; 52: 629-635.
46. Fernandez-Cuenca F, Martinez-Martinez L, Conejo MC et al. Relationship between beta-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii. J Antimicrob Chemother 2003; 51: 565-574.
47. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 16th informational supplement. M100-S16. Wayne, PA: CLSI, 2006.